ENIMED LIMITEDActive

Company number 06281747Private limited companyIncorporated 2007

Key figures

£16,918,288+9.9%
Net assets 2024/25
+9.9%
Average annual growth 2023/24–2024/25
05 m10 m15 m20 m2023/242024/25

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 m40 m2023/242024/25

Dividends

from the accounts
2024/25

Dividends paid in the financial year: £51,000 (3% of the profit for the year).

History
2024/25£51,000
2023/24£39,000
Filed accounts2023/24–2024/25
2023/242024/25
Turnover44,886,01050,634,795
Profit for the year1,332,5041,576,660
Cash at bank and in hand2,414,6032,079,561
Total assets36,468,77337,458,753
Total liabilities21,006,64320,069,178
Net assets / total equity15,392,62816,918,288
Average number of employees289290
Average pay (per year)20,31222,110
Dividends paid-39,000-51,000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ENIMED LIMITED

Company

ENIMED LIMITED is a private limited company registered with Companies House under company number 06281747. It was incorporated on 15 Jun 2007. Its status is active. The registered office is in Eastcote (HA5). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files full accounts. Turnover was £50,634,795. Profit for the year was £1,576,660. Net assets were £16,918,288, up 9.9% on the previous year. Cash at bank and in hand was £2,079,561. Total assets were £37,458,753 and total liabilities £20,069,178. The company had an average of 290 employees. Figures are available for 2 financial years (2023/24–2024/25).

Control and charges

One person with significant control is registered. 5 of 14 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 24 Jul 2027.